Top Markets
Coin of the day
Impact BioMedical Inc. Impact BioMedical Inc.

Impact BioMedical Inc.

IBO
株式のランク #25450
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
株価
$0.4587
最終同期: 2026-08-20
時価総額
$49.46M
変化(1日)
5.89%
変化(1年)
-22.83%
US
取引 Impact BioMedical Inc. (IBO)

カテゴリー

Impact BioMedical Inc.(IBO)の配当利回りの履歴
Impact BioMedical Inc.(銘柄コード: IBO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Impact BioMedical Inc.(IBO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)